Skip to main content

What the FDA labels say about taking them together

Vitamin a and vutrisiran

Vutrisiran's FDA label of November 6, 2025 names vitamin a in its warnings and precautions section; the vitamin a label PlainMeds reads does not name vutrisiran. The vutrisiran label: “WARNINGS AND PRECAUTIONS Reduced serum vitamin A levels and recommended supplementation: Supplement with the recommended daily allowance of vitamin A. …”

Check it at the source: the vitamin a FDA label on DailyMed (effective March 3, 2026, Rising Pharma Holdings, Inc.); the vutrisiran FDA label on DailyMed (effective November 6, 2025, Alnylam Pharmaceuticals, Inc.).

What does the vitamin a label say about vutrisiran?

Vitamin a's label (effective March 3, 2026) does not name vutrisiran in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (AQUASOL A Parenteral), Rising Pharma Holdings, Inc., effective March 3, 2026 (SPL set 1abd66eb-6ac8-4a9e-a609-251e46ea1a27), via openFDA; the full label on DailyMed

What does the vutrisiran label say about vitamin a?

Vutrisiran label, warnings and precautions

WARNINGS AND PRECAUTIONS Reduced serum vitamin A levels and recommended supplementation: Supplement with the recommended daily allowance of vitamin A. Refer to an ophthalmologist if ocular symptoms suggestive of vitamin A deficiency occur.

Source: FDA drug label (AMVUTTRA), Alnylam Pharmaceuticals, Inc., effective November 6, 2025 (SPL set 8db0facb-81b6-4006-9239-27dc6409c5d3), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Vitamin a generic labelers
0Vutrisiran generic labelers
Vitamin aVutrisiran
Labeled forn/aHeart failure
Boxed warningNoNo
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?